Modern possibilities of treatment of chronic inflammatory diseases of the genital organs in women of fertile age
Authors: Vl.V. Podolsky, V.V. Podolsky, SE «Institute of Pediatrics, Obstetrics and Gynecology of the National Academy of Medical Sciences of Ukraine», Kyiv
To evaluate the outpatient treatment of chronic pelvic inflammatory diseases of fertile aged women caused by mixed infection, including Chlamydia.
We examined 100 women chronic pelvic inflammatory diseases determining vaginal microbiota condition before and after treatment. Provided research of efficiency in the treatment of drug containing ciprofloxacin – and ornidazole 500 mg – 500 mg (Ortsypol) in women with chronic pelvic inflammatory diseases in lower levels of genital tract.
Analysis of the vaginal bacterial spectrum and records of the results was performed according to the order number 234 of the Ministry of Health of Ukraine 2005
Our results have shown that most women suffered from chronic pelvic inflammatory diseases in lower level of genital tract during one year (30%), slightly less women had disease duration of 3 years (27%) and 5 years (25%).
Among other gynecological diseases in examined women often diagnosed cervical erosion (14%) and the polycystic ovarian syndrome (18%). Often diagnosed ovarian cysts (10%), endometriosis (11%) and endometrial hyperplasia (9%).
Examination of vaginal mikrobiome in fertile aged women with chronic pelvic inflammatory diseases showed increased number of resident microflora and STIs, mainly: Chlamidya trahomatis (25%), Ureaplasma urealiticum (23%).
We observed significant reduction of the number of pathogenic and conditionally pathogenic microflora in fertile aged women with chronic pelvic inflammatory diseases after treatment rizke.
Key words: chronic inflammatory diseases, fertile aged women, infections, sexually transmitted infections, outpatient treatment, Ortsypol.
Article in PDF
View